There is a lot of macro "noise" in the market right now, as one Wall Street analyst called it, with higher tariffs, changes ...

Notably, the companys EBITDA surged by 16.5 percent, increasing from Rs 586.3 crore to Rs 683.2 crore from previous year.

The Wasatch Ultra Growth Fund—Investor Class underperformed the benchmark with a return of -14.81%. Read more here.

The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

Dividend growth stocks have long been reliable engines of wealth creation. Historically, companies with 10-year annualized ...

From recycling batteries to autonomous delivery drones, these are the innovators building the future. And this year, they're ...

Vertex Pharmaceuticals should have big winners with pain drug Journavx and two promising pipeline candidates. Summit ...

Sun Pharma is expected to reflect continued strength in specialty and chronic therapies, with margin improvement and robust ...

BioSpace examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made ...

With positive sentiment around the NIFTY 50, as per Moneycontrol analysis, stocks from diverse sectors are exhibiting strong ...

Positioned to Unlock M&A Value through U.S. Manufacturing Amidst Geopolitical Complexities and Specialty Portfolio ...

TrialWire is the AI and algorithm-powered patient-recruitment and enrollment platform, purpose-built on Salesforce Health Cloud to guarantee best-in-class data and IP security.